首页> 外国专利> Analyzing genetic predisposition to disease, e.g. rheumatoid polyarthritis, by amplification then hybridization to low- and high-resolution oligonucleotide probes

Analyzing genetic predisposition to disease, e.g. rheumatoid polyarthritis, by amplification then hybridization to low- and high-resolution oligonucleotide probes

机译:分析疾病的遗传易感性,例如类风湿性关节炎,通过扩增然后与低分辨率和高分辨率寡核苷酸探针杂交

摘要

Analyzing genetic predisposition to at least one disease, comprising treating a liquid sample, containing at least one type of amplicon derived from at least one polymorphic region (PMR) related to the disease, with at least one type-specific probe (P1; low resolution), and at least one subtype-specific probe (P2; high resolution), is new. Analyzing genetic predisposition to at least one disease, comprising treating a liquid sample, containing at least one type of amplicon derived from at least one polymorphic region (PMR) related to the disease, with at least one type-specific probe (P1; low resolution), and at least one subtype-specific probe (P2; high resolution), is new. P1 hybridizes to at least one gene, or a group of alleles of the gene, present in the amplicon and P2 hybridizes to the allele, or group of alleles, specific to P1. P2 can discriminate between one or more alleles associated with susceptibility and/or those alleles associated with resistance to disease, according to whether they hybridize or not. Independent claims are also included for the following: (1) amplification of a sequence corresponding to the group of DRB1 asterisk gr04 alleles using primers (20) and (21); (2) amplification of a sequence corresponding to the B27 allele using primers (22), (23) and/or (25) plus (24) and/or (26); and (3) combined amplification products of (1) and (2). CCGGATCCTTCGTGTCCCCACAGCACG (20); TCGCCGCTGCACTGTGAAG (21); GGGAGGAGCGAGGGGACCCCAG (22); GGGAGGAGCGAGGGGACCGCAG (23); ATCTCGGACCCGGAGACT (24); AGGGGACCGCA (25); and ATCTCGGACCCGGAGACTCG (26).
机译:分析至少一种疾病的遗传易感性,包括使用至少一种类型特异性探针(P1;低分辨率)处理液体样品,该液体样品含有至少一种类型的扩增子,所述扩增子衍生自与疾病相关的至少一个多态性区域(PMR) ),并且至少有一个亚型特异性探针(P2;高分辨率)是新的。分析至少一种疾病的遗传易感性,包括使用至少一种类型特异性探针(P1;低分辨率)处理液体样品,该液体样品含有至少一种类型的扩增子,所述扩增子衍生自与疾病相关的至少一个多态性区域(PMR) ),并且至少有一个亚型特异性探针(P2;高分辨率)是新的。 P1与存在于扩增子中的至少一个基因或该基因的一组等位基因杂交,并且P2与对P1特异的等位基因或等位基因组杂交。 P2可以根据是否杂交来区分一个或多个与易感性相关的等位基因和/或与抗病性相关的那些等位基因。还包括以下方面的独立权利要求:(1)使用引物(20)和(21)扩增对应于DRB1星号gr04等位基因组的序列; (2)使用引物(22),(23)和/或(25)加上(24)和/或(26)扩增对应于B27等位基因的序列; (3)(1)和(2)的组合扩增产物。 CCGGATCCTTCGTGTCCCCACAGCACG(20); TCGCCGCTGCACTGTGAAG(21); GGGAGGAGCGAGGGGACCCCAG(22); GGGAGGAGCGAGGGGACCGCAG(23); ATCTCGGACCCGGAGACT(24); AGGGGACCGCA(25);和ATCTCGGACCCGGAGACTCG(26)。

著录项

  • 公开/公告号FR2793809A1

    专利类型

  • 公开/公告日2000-11-24

    原文格式PDF

  • 申请/专利权人 BIOMERIEUX;

    申请/专利号FR19990015314

  • 发明设计人 MOUGIN BRUNO;TIERCY JEAN MARIE;

    申请日1999-12-06

  • 分类号C12Q1/68;

  • 国家 FR

  • 入库时间 2022-08-22 01:07:58

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号